MedTrace Logo

Determining Beta-hCG Levels in Patients Through Alternative Sample Types

NCT06178224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-12-20

No results posted yet for this study

Summary

This study is to determine if there is any quantifiable correlation between serum beta hCG and dried blood spot (DBS) beta hCG levels. This data will be used to develop a less invasive collection method to determine quantitative hCG levels.

Conditions

  • Pregnancy Related
  • Abortion

Sponsors & Collaborators

  • Planned Parenthood Federation of America

    collaborator OTHER

  • Planned Parenthood Great Northwest, Hawai'I, Alaska, Indiana, Kentucky

    collaborator UNKNOWN

  • Simple HealthKit

    lead INDUSTRY

Principal Investigators

  • Erin Berry, MD · Planned Parenthood Great Northwest, Hawai'I, Alaska, Indiana, Kentucky

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-11
Primary Completion
2023-04-19
Completion
2023-06-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06178224 on ClinicalTrials.gov